Search results
14 hours ago · AbbVie ( NYSE:ABBV – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided EPS guidance of 10.610-10.810 for the period, compared to the ...
3 days ago · For fiscal 2024, AbbVie is now expecting adjusted diluted earnings per share to be in a range of $11.13 to $11.33 (compared to a previous guidance of $10.97 to $11.17). AbbVie does not offer any ...
6 days ago · AbbVie is paying $150 million upfront for rights to Chinese biotech FutureGen Biopharmaceutical’s FG-M701, described as a next-generation antibody that binds to tumour necrosis factor-like ...
4 days ago · AbbVie Inc.: Forcasts, revenue, earnings, analysts expectations, ratios for AbbVie Inc. Stock | ABBV | US00287Y1091
3 days ago · AbbVie has increased its dividend for the past 52 consecutive years. When did AbbVie last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.07 on Friday, October 27, 2023.
3 days ago · AbbVie (NYSE:ABBV) pays an annual dividend of $6.20 per share and currently has a dividend yield of 3.61%. The company has been increasing its dividend for 52 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 183.98%.
3 days ago · Abbvie Inc is a leading biopharmaceutical company that develops and markets innovative therapies for various diseases. Find out the latest share price, charts, analysis, forecasts and business profile of Abbvie Inc on FT.com, the authoritative source for global business news and insights.
